More recently, using cannabis as a medicine has become even more commonplace, especially in countries where legalization efforts have made it a legitimate alternative to more potent medications.
Now, an Israeli company has teamed up with the folks at Soroka University, engaging in one of the most extensive clinical trials to date.
Conducted over several years, the trial focused on 8,500 Israeli men and women with an average age of 54.6 years.
For example, a number of the patients either reduced their medications usage when using cannabis or stopped taking those other medications altogether.
Last year, Cannbit-Tikun Olam signed a distribution agreement with Teva Pharmaceuticals to bring their products to a broader Israeli and Palestinian market.